Novartis now expects its core operating profit to grow in the mid to high teens, after second-quarter results outpaced analysts’ expectations, boosted by revenue from its blockbuster treatments.
Related Posts
Energy & Utilities Roundup: Market Talk
- staff
- January 15, 2025
- 0
Read about oil prices, commodities trading on the ICE, OMV and more in the latest Market Talks covering Energy and Utilities.
Energy & Utilities Roundup: Market Talk
- staff
- January 13, 2025
- 0
Find insight on Shell, Galp, Techtronic Industries and more in the latest Market Talks covering Energy and Utilities.
Luxury Brands Increase Prices in Japan Amid Sales Surge, Yen Weakness
Some luxury brands are pushing through price increases in Japan, as tourists snapping up high-end goods turn the country into a bright spot for an […]